Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001062993-21-007697 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | 2021-08-13 | SRTA | Tomkiel Melissa M. | Pres, GC | A - Grant | $0.00 | +157.6K | 379.5K | +71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2021-08-13 | A | A | 157,583 | $0.00 | 379,508 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer. |